Reciprocal modulation between Sp1 and Egr-1 - PubMed (original) (raw)
. 1997 Sep 15;66(4):489-99.
Affiliations
- PMID: 9282327
Reciprocal modulation between Sp1 and Egr-1
R P Huang et al. J Cell Biochem. 1997.
Abstract
Many ubiquitously expressed genes, including oncogenes, lack a proximal TATA or CAAT box but have a region of G + C-rich sequences that appears to replace the usual promoter initiation site. The zinc-finger protein Sp1 is one of the prevalent activators of these genes. The Egr-1 zinc-finger protein has a similar binding site and if the two sites occur in the same region, a variety of activation or inhibitory responses may be obtained. We show that competition between the two factors for overlapping sites on growth-promoting genes could explain why the overexpression of Egr-1 suppresses transformed growth in a number of cell types [Huang et al. (1995): Cancer Res 55:5054-5062; Huang et al. (1997): Int J Cancer]. We demonstrate here that Egr-1 and Sp1 can bind to the same G + C-rich sites and that Egr-1 can displace Sp1 and hence inhibit its activity. We measured the responses of synthetic consensus binding sites and natural promoter sequences linked to a reporter gene and showed that Egr-1 inhibited the activation of transcription by Sp1 on overlapping Sp1/Egr-1 sites. In contrast, Sp1 activity could be augmented by Egr-1 at nonoverlapping sites in the Egr-1 gene promoter, in transient reporter gene studies in Drosophila SL2 cells. In addition, over-expression of exogenous Sp1 in mammalian cells, also leads to increased Egr-1 protein expression, which further inhibits Sp1 transactivation of numerous genes. Therefore, we can account for some of the complex responses of G + C-rich enhancer/promoters by a form of "facilitated inhibition" of Sp1 by Egr-1 at overlapping sites.
Similar articles
- Egr-1 and Sp1 interact functionally with the 5-lipoxygenase promoter and its naturally occurring mutants.
Silverman ES, Du J, De Sanctis GT, Rådmark O, Samuelsson B, Drazen JM, Collins T. Silverman ES, et al. Am J Respir Cell Mol Biol. 1998 Aug;19(2):316-23. doi: 10.1165/ajrcmb.19.2.3154. Am J Respir Cell Mol Biol. 1998. PMID: 9698605 - Coordinate expression and distinct DNA-binding characteristics of the four EGR-zinc finger proteins in Jurkat T lymphocytes.
Skerka C, Decker EL, Zipfel PF. Skerka C, et al. Immunobiology. 1997 Dec;198(1-3):179-91. doi: 10.1016/S0171-2985(97)80039-3. Immunobiology. 1997. PMID: 9442390 - Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z, Maher VM, McCormick JJ. Lou Z, et al. Gene. 2005 May 23;351:51-9. doi: 10.1016/j.gene.2005.02.007. Epub 2005 Apr 25. Gene. 2005. PMID: 15857802 - Regulation of the tissue factor gene.
Mackman N. Mackman N. Thromb Haemost. 1997 Jul;78(1):747-54. Thromb Haemost. 1997. PMID: 9198250 Review.
Cited by
- PTEN in kidney diseases: a potential therapeutic target in preventing AKI-to-CKD transition.
Cao F, Li Y, Peng T, Li Y, Yang L, Hu L, Zhang H, Wang J. Cao F, et al. Front Med (Lausanne). 2024 Aug 6;11:1428995. doi: 10.3389/fmed.2024.1428995. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39165377 Free PMC article. Review. - Interleukin-1ß Attenuates Expression of Augmenter of Liver Regeneration (ALR) by Regulating HNF4α Independent of c-Jun.
Nimphy J, Ibrahim S, Dayoub R, Kubitza M, Melter M, Weiss TS. Nimphy J, et al. Int J Mol Sci. 2023 Apr 30;24(9):8107. doi: 10.3390/ijms24098107. Int J Mol Sci. 2023. PMID: 37175814 Free PMC article. - Serine 26 in Early Growth Response-1 Is Critical for Endothelial Proliferation, Migration, and Network Formation.
Santiago FS, Li Y, Khachigian LM. Santiago FS, et al. J Am Heart Assoc. 2021 Sep 21;10(18):e020521. doi: 10.1161/JAHA.120.020521. Epub 2021 Sep 3. J Am Heart Assoc. 2021. PMID: 34476983 Free PMC article. - Friend or foe, the role of EGR-1 in cancer.
Li TT, Liu MR, Pei DS. Li TT, et al. Med Oncol. 2019 Nov 20;37(1):7. doi: 10.1007/s12032-019-1333-6. Med Oncol. 2019. PMID: 31748910 Review. - Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network.
Inoue K, Fry EA. Inoue K, et al. Cancer Invest. 2018;36(9-10):520-536. doi: 10.1080/07357907.2018.1533965. Epub 2018 Nov 5. Cancer Invest. 2018. PMID: 30396285 Free PMC article.